Dyne Therapeutics, Inc. — SC 13G Filings
15 SC 13G filings on record
This page lists all SC 13G filings submitted to the SEC by Dyne Therapeutics, Inc. (DYN), sorted by most recent first. Each row links to the full filing on EdgarLookup. Dyne Therapeutics, Inc. has filed 15 SC 13G documents with the SEC since 2020. To view all SEC filings by Dyne Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
3
3/A
4
4/A
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
EFFECT
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-3MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G | — | 0000902664-24-006495 | Nov 14, 2024 | — |
| SC 13G | — | 0000315066-24-002763 | Nov 12, 2024 | — |
| SC 13G | SC 13G | 0001104659-24-043728 | Apr 4, 2024 | — |
| SC 13G | — | 0001086364-24-005064 | Jan 29, 2024 | — |
| SC 13G | — | 0001172661-24-000285 | Jan 19, 2024 | — |
| SC 13G | — | 0001306550-23-008504 | Feb 9, 2023 | — |
| SC 13G | — | 0001306550-23-008395 | Feb 8, 2023 | — |
| SC 13G | — | 0001172661-22-000161 | Jan 20, 2022 | — |
| SC 13G | — | 0000935836-21-000464 | Aug 16, 2021 | — |
| SC 13G | SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP | 0001839882-21-002170 | Feb 16, 2021 | — |
| SC 13G | SC 13G | 0001104659-21-024259 | Feb 16, 2021 | — |
| SC 13G | SC 13G | 0001193125-21-043262 | Feb 16, 2021 | — |
| SC 13G | SC 13G | 0001193125-21-041618 | Feb 12, 2021 | — |
| SC 13G | SEC SCHEDULE 13G | 0000902219-21-000092 | Feb 3, 2021 | — |
| SC 13G | SC 13G | 0001104659-20-109295 | Sep 28, 2020 | — |